Skip to main content

Table 1 Baseline characteristics of the patients included in the study.

From: A prospective, randomised, controlled clinical study on the assessment of tolerability and of clinical efficacy of Merional (hMG-IBSA) administered subcutaneously versus Merional administered intramuscularly in women undergoing multifollicular ovarian stimulation in an ART programme (IVF)

 

Merional s.c.

Merional i.m.

P value

N. of patients randomised

85

83

 

Age (years)*

34.6 ± 4.9

34.4 ± 5.2

NS

Diagnosis of male factor (%)

48

51

NS

Diagnosis of unexplained infertility (%)

18

17

NS

Diagnosis of tubal factor (%)

24

25

NS

Endometriosis (%)

10

7

NS

Proportion of ICSI (%)

53

54

NS

  1. * Values expressed as mean ± SD.